Recombinant Mouse 5-hydroxytryptamine receptor 4 (Htr4)

What is Recombinant Mouse 5-hydroxytryptamine receptor 4 (Htr4)?

Recombinant Mouse 5-hydroxytryptamine receptor 4 (Htr4) is a laboratory-produced form of the mouse serotonin 4 receptor protein. It is commonly referred to by several names including 5-HT4, 5HTR4, and 5-HT<4L>. This recombinant protein is specifically engineered for research applications investigating serotonergic signaling systems. The protein is typically produced through heterologous expression in various host systems and purified to ≥85% purity as determined by SDS-PAGE analysis .

Functionally, Htr4 belongs to the broader family of serotonin receptors that mediate the effects of the neurotransmitter serotonin (5-hydroxytryptamine). While the search results don't provide specific details about Htr4 function, serotonin receptors generally play crucial roles in neuronal signaling, mood regulation, and various physiological processes.

What expression systems are available for producing Recombinant Mouse Htr4?

Recombinant Mouse Htr4 can be produced in multiple expression systems depending on the research requirements. According to the available data, the following expression systems are commonly employed:

Each expression system offers distinct advantages based on the intended application. Selection should be made based on project requirements for protein folding, post-translational modifications, and functional activity .

How is the quality of Recombinant Mouse Htr4 typically assessed?

Quality assessment of Recombinant Mouse Htr4 involves multiple analytical techniques to ensure protein integrity and functionality:

• Purity Analysis: SDS-PAGE is the primary method used to determine protein purity, with commercial preparations typically achieving ≥85% purity .

• Identity Confirmation: While not explicitly mentioned in the search results, Western blotting using specific antibodies would typically be used to confirm protein identity.

• Functional Testing: Although specific methods for Htr4 are not detailed in the search results, functional assays might include ligand binding assays, signaling pathway activation measurements, or receptor internalization studies.

• Structural Integrity: Techniques such as circular dichroism spectroscopy might be employed to verify proper protein folding, though this isn't specifically mentioned in the search results.

Researchers should carefully review quality control documentation when selecting recombinant proteins for their experiments to ensure consistency and reproducibility.

What methodological considerations are important when designing experiments with Recombinant Mouse Htr4?

When designing experiments utilizing Recombinant Mouse Htr4, several methodological considerations require attention:

How can researchers effectively validate the functionality of recombinant Htr4 proteins?

Validating the functionality of recombinant Htr4 proteins requires a multi-faceted approach:

• Ligand Binding Assays: While specific assays for Htr4 aren't detailed in the search results, radioligand binding using selective 5-HT4 ligands would typically be employed to confirm the receptor retains its binding pocket integrity.

• G-protein Coupling: As a G-protein coupled receptor, Htr4 functionality can be assessed through downstream signaling activation, typically measuring cAMP production since 5-HT4 receptors primarily couple to Gαs proteins.

• Receptor Trafficking: Fluorescently-tagged Htr4 can be monitored for appropriate subcellular localization and internalization dynamics following agonist exposure.

• Comparative Analysis: Parallel testing of recombinant Htr4 alongside native receptors in appropriate cellular contexts can provide validation of physiological relevance.

• Antibody Recognition: Specific antibodies can verify the structural integrity of epitopes, similar to the approach used for human 5-HT4 detection described in the search results .

What strategies can address challenges in expressing functional membrane proteins like Htr4?

Expressing functional serotonin receptors presents several challenges due to their transmembrane nature. Effective strategies include:

• Expression System Optimization: For Htr4, mammalian expression systems often provide the most functionally relevant protein due to appropriate chaperone proteins and post-translational modification machinery .

• Fusion Partners: Consider employing fusion tags that enhance expression and folding, such as SUMO or MBP tags, which can be later removed if necessary.

• Stabilizing Mutations: Introduction of specific mutations that enhance thermostability without affecting function can improve expression yields.

• Lipid Environment Reconstitution: Purified receptor proteins can be reconstituted into nanodiscs, liposomes, or other membrane mimetics to maintain native-like structure and function.

• Truncation Strategies: For certain applications, expressing specific domains rather than the full-length receptor may improve yields while preserving the functionality of interest.

How do findings from 5-HT receptor studies in mouse models inform broader serotonergic system research?

Mouse models provide valuable insights into serotonergic system function with several important considerations:

• Translational Relevance: While mouse and human serotonin receptors share significant homology, species differences exist in pharmacological profiles and tissue distribution. These must be accounted for when extrapolating findings to human physiology.

• Genetic Manipulation Insights: Studies with knockout mice have revealed critical roles of serotonin signaling in anxiety-related behaviors. For instance, research with 5-HTT knockout mice demonstrated that alterations in serotonergic transmission produce robust phenotypic abnormalities in anxiety tests, which were reversible with selective 5-HT1A receptor antagonists .

• Compensatory Mechanisms: Genetic manipulations often trigger compensatory changes in other components of the serotonergic system. In 5-HTT knockout mice, prolonged clearance of serotonin leads to nine-fold increases in extracellular serotonin and consequent receptor downregulation .

• Behavioral Phenotyping: Mouse models with altered serotonin receptor expression provide opportunities to correlate molecular changes with behavioral outcomes using standardized tests such as elevated plus maze, light-dark exploration, and open field tests .

• Pharmacological Validation: Selective ligands can be used to validate the role of specific receptors in observed phenotypes, as demonstrated with the 5-HT1A antagonist WAY 100635, which produced anxiolytic effects in 5-HTT knockout mice but not in wild-type controls .

What experimental approaches can distinguish the functional contributions of Htr4 from other serotonin receptor subtypes?

Differentiating the functional contributions of Htr4 from other serotonin receptor subtypes requires specialized experimental approaches:

• Pharmacological Profiling: Employ subtype-selective agonists and antagonists with documented selectivity profiles. For Htr4, compounds like RS-67506 (agonist) and GR-113808 (antagonist) provide reasonable selectivity.

• Genetic Approaches: Utilize Htr4 knockout mouse models or RNA interference techniques to specifically downregulate Htr4 expression while monitoring for compensatory changes in other receptor subtypes.

• Biased Signaling Analysis: Different serotonin receptor subtypes couple to distinct G-proteins and signaling pathways. Monitoring pathway-specific outcomes (e.g., cAMP for Gs-coupled Htr4 versus Ca2+ mobilization for Gq-coupled receptors) can help differentiate subtype contributions.

• Cellular Expression Patterns: Immunohistochemical approaches similar to those described for human 5-HT4 can map the distribution of Htr4 versus other receptor subtypes, informing region-specific functions.

• Temporal Dynamics: Different receptor subtypes exhibit characteristic desensitization and internalization kinetics. Time-course experiments can help distinguish acute versus sustained signaling contributions.

What detection methods are most effective for Htr4 localization and expression studies?

While the search results don't provide specific information for mouse Htr4 detection, parallel approaches to those used for human 5-HT4 would likely be effective:

• Immunohistochemistry: Similar to the approach described for human 5-HT4 in brain cortex sections, immunohistochemical staining can visualize Htr4 distribution in mouse tissues. This typically involves specific antibodies, appropriate epitope retrieval techniques, and visualization systems such as HRP-polymer antibodies with DAB staining .

• Flow Cytometry: For cell populations expressing Htr4, flow cytometric analysis using specific antibodies can quantify receptor expression levels across different experimental conditions .

• Western Blotting: While not specifically mentioned in the search results, Western blotting would provide quantitative assessment of total Htr4 protein levels in tissue or cell lysates.

• RT-PCR/qPCR: For transcript-level analysis, reverse transcription followed by PCR or quantitative PCR can measure Htr4 mRNA expression.

• Radioligand Binding: Tissue-section autoradiography using selective radioligands can map functional receptor distribution with high sensitivity.

How can researchers optimize transfection protocols for studies requiring Htr4 overexpression?

Optimizing transfection protocols for Htr4 overexpression studies requires consideration of several factors:

• Cell Line Selection: Choose cell lines with low endogenous expression of serotonin receptors to minimize background effects. HEK293 cells are commonly used for serotonin receptor studies, as evidenced by their use in human 5-HT4 research .

• Construct Design: Include appropriate tags (e.g., fluorescent proteins like eGFP) to monitor transfection efficiency and protein localization without compromising receptor function .

• Transfection Method Optimization: Compare lipid-based, electroporation, and viral transduction methods to identify optimal conditions for Htr4 expression. Parameters including DNA:transfection reagent ratio, cell density, and post-transfection incubation time should be systematically optimized.

• Expression Verification: Utilize multiple detection methods to confirm successful expression, including flow cytometry for quantification and microscopy for localization .

• Functional Validation: Employ functional assays to verify that the overexpressed Htr4 retains signaling capabilities, as structural integrity does not guarantee functionality.

What emerging technologies might advance understanding of Htr4 function in neural circuits?

Several emerging technologies offer promising approaches for investigating Htr4 function in neural circuits:

• CRISPR-Cas9 Gene Editing: Precise modification of endogenous Htr4 genes to introduce reporter tags or functional mutations can provide insights into receptor dynamics in physiologically relevant contexts.

• Optogenetic Receptor Control: Development of light-sensitive Htr4 variants would allow temporal control over receptor activation in specific neural populations.

• Chemogenetic Approaches: Designer Receptors Exclusively Activated by Designer Drugs (DREADDs) based on Htr4 structure could enable selective modulation of Htr4-expressing neurons.

• Single-Cell Transcriptomics: Analysis of Htr4 expression patterns at single-cell resolution can reveal cell type-specific roles across brain regions and developmental stages.

• Cryo-EM Structural Studies: High-resolution structural determination of mouse Htr4 in different conformational states would inform structure-based drug design targeting this receptor subtype.

How might comparative studies between serotonin receptor subtypes inform therapeutic development?

Comparative studies across serotonin receptor subtypes can guide therapeutic development through several approaches:

• Subtype-Selective Pharmacology: Understanding the structural and functional differences between Htr4 and other serotonin receptors can inform the development of highly selective compounds with reduced off-target effects.

• Signaling Bias Exploitation: Different receptor subtypes exhibit unique signaling profiles. Identifying beneficial signaling pathways specific to Htr4 could lead to biased ligands that selectively activate therapeutic pathways while minimizing unwanted effects.

• Region-Specific Functions: Mapping the distribution and function of Htr4 compared to other serotonin receptors across brain regions can identify circuit-specific therapeutic opportunities.

• Developmental Regulation: Comparing the developmental expression patterns of different receptor subtypes may reveal critical periods when Htr4-targeted interventions would be most effective.

• Translational Models: Building on findings from studies like those with 5-HTT knockout mice , comparative analysis of phenotypes across receptor-specific genetic models can identify the most promising therapeutic targets for specific neuropsychiatric conditions.